December 31, 2019, respectively. Meanwhile, the cost of hospital operations to revenue ratios stood at 71.17% and 68.84%, respectively. The lower ratio on a year-on-year basis was attributable to the Company
higher ratio on a year-on-year basis was attributable to the Company has some costs in personnel and system that prepared to new hospital building. Selling expenses The Company booked selling expenses
period ended June 30, 2018, respectively. Meanwhile, the cost of hospital operations to revenue ratios stood at 69.41% and 67.40%, respectively. The lower ratio on a period-on-period basis was attributable
from the heads quarter in approximately 265 Million Baht. There will no impact on shareholders’ benefits. If the Company drawdowns loan from financial institution, debt to equity ratio will be increased
further business expansion from rapidly growth of demand for loans and comply with the new requirement of D/E ratio issued by Financial Regulatory Department (FRD) in Myanmar. Details of Capital Injection
เพือ่สรา้งรายไดท้ีย่ ัง่ยนืในระยะยาว โดยคาดว่าจะสามารถเปิดใหบ้รกิารไดใ้นชว่งกลางปี 2563 นอกจากนี้ ยงัชว่ยรกัษาอตัราสว่นหนี้สนิทีม่ภีาระ ดอกเบีย้ต่อทนุ (Interest bearing debt ratio) ใหม้อีตัราคงทีเ่มือ่เปร
shareholders at the ratio of 4 existing ordinary shares for 3 newly-issued ordinary shares at Baht 10 per share. The subscription and payment period for the newly-issued ordinary shares is 31 July 2018 – 20
the ratio of 4 existing ordinary shares for 3 newly-issued ordinary shares at Baht 10 per share. The subscription and payment period for the newly-issued ordinary shares is 31 July 2018 – 20 December
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Total comprehensive income for the period 397.89 17.65 69.02 8.94 402.90 17.79 78.88 10.02 328.87 476.49 Note: The ratio in the income statement is
Return on equity (ROE) -9.52% 2.01% 2.95% 14.77% 13.11% Return on asset (ROA) -3.52% 0.75% 1.06% 5.14% 4.59% Interest bearing Debt / Equity (IBD/Equity) 1.28 1.22 1.12 1.05 0.98 Return on equity (ROE) and